These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27578213)

  • 1. Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET.
    Barron AM; Tokunaga M; Zhang MR; Ji B; Suhara T; Higuchi M
    J Neuroinflammation; 2016 Aug; 13(1):221. PubMed ID: 27578213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
    Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
    J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Müller L; Power Guerra N; Schildt A; Lindner T; Stenzel J; Behrangi N; Bergner C; Alberts T; Bühler D; Kurth J; Krause BJ; Janowitz D; Teipel S; Vollmar B; Kuhla A
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases.
    Biechele G; Franzmeier N; Blume T; Ewers M; Luque JM; Eckenweber F; Sacher C; Beyer L; Ruch-Rubinstein F; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Cumming P; Bartenstein P; Rominger A; Höglinger GU; Herms J; Brendel M
    J Neuroinflammation; 2020 Dec; 17(1):374. PubMed ID: 33317543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation.
    Savonenko AV; Melnikova T; Wang Y; Ravert H; Gao Y; Koppel J; Lee D; Pletnikova O; Cho E; Sayyida N; Hiatt A; Troncoso J; Davies P; Dannals RF; Pomper MG; Horti AG
    PLoS One; 2015; 10(6):e0129618. PubMed ID: 26086915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model.
    Sacher C; Blume T; Beyer L; Peters F; Eckenweber F; Sgobio C; Deussing M; Albert NL; Unterrainer M; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Brzak I; Neumann U; Saito T; Saido TC; Bartenstein P; Rominger A; Herms J; Brendel M
    J Nucl Med; 2019 Dec; 60(12):1787-1793. PubMed ID: 31302633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography.
    Rejc L; Gómez-Vallejo V; Joya A; Arsequell G; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Iglesias L; Capetillo-Zarate E; Ramos-Cabrer P; Martin A; Llop J
    Alzheimers Res Ther; 2022 Jun; 14(1):80. PubMed ID: 35676734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
    Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
    J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study.
    Blume T; Focke C; Peters F; Deussing M; Albert NL; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Ozmen L; Baumann K; Bartenstein P; Rominger A; Herms J; Brendel M
    J Neuroinflammation; 2018 Nov; 15(1):307. PubMed ID: 30400912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
    Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M
    J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in App
    Biechele G; Wind K; Blume T; Sacher C; Beyer L; Eckenweber F; Franzmeier N; Ewers M; Zott B; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Tahirovic S; Willem M; Bartenstein P; Cumming P; Rominger A; Herms J; Brendel M
    Neuroimage; 2021 Apr; 230():117707. PubMed ID: 33385560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1-42) in mice.
    Garcez ML; Mina F; Bellettini-Santos T; Carneiro FG; Luz AP; Schiavo GL; Andrighetti MS; Scheid MG; Bolfe RP; Budni J
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():23-31. PubMed ID: 28336494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
    Cai Y; Shi D; Lan G; Chen L; Jiang Y; Zhou L; Guo T;
    Neurology; 2024 Apr; 102(7):e209205. PubMed ID: 38489560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer's Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers.
    Gavriel Y; Rabinovich-Nikitin I; Ezra A; Barbiro B; Solomon B
    J Alzheimers Dis; 2020; 78(2):653-671. PubMed ID: 33016905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
    Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
    Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in β-amyloid rat model of Alzheimer's disease.
    Xuan A; Long D; Li J; Ji W; Zhang M; Hong L; Liu J
    J Neuroinflammation; 2012 Aug; 9():202. PubMed ID: 22898621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.